Clinical Trials
7 trialsNCT02329106 2021-09-05
Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02333773 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT03183219 2020-07-13
Safety and Efficiency of γδ T Cell Against Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02828865 2020-07-07
A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
National Taiwan University Hospital
Phase NA Completed
NCT02787954 2018-10-18
Liver
The University of Texas Health Science Center, Houston
Terminated
NCT02010801 2013-12-13
Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors
National Taiwan University Hospital
Phase NA Completed
NCT01442324 2012-07-18
Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
Azienda Ospedaliera di Padova
Phase NA Unknown